Venture-Backed Startups

Biocom (operated by Allostar Inc.) offers scientific biodata analysis services—such as comprehensive metabolic function testing, food intolerance analysis, and stress/aging assessments—paired with personalized diet, nutrition, sleep, and exercise solutions, health foods, and management challenge programs. It sells these tests, supplements, and membership benefits to consumers through its official online store in South Korea.

1 investor

Biocomposites is a British company that develops and manufactures bone cement products used by surgeons in orthopaedic and surgical procedures. Its SYNICEM line is distributed globally and being expanded to serve UK NHS demand.

1 investor

BioCompute is developing DNA-based data storage technology, offering exclusive pilot programs for early access. The company operates in the data storage and biotechnology space.

1 investor

1 investor

BioConnection is a contract manufacturing organization (CMO) providing aseptic fill & finish services and freeze-drying (lyophilization) for sterile pharmaceutical drug products at clinical and commercial scale. It also offers formulation and analytical development, packaging, tech transfer, and regulatory support to biopharma clients from its EMA- and US-FDA-approved facilities in the Netherlands.

1 investor

Endobits is clinical decision-support software that runs on top of FDA-cleared continuous glucose monitors to help qualified healthcare professionals and clinics manage glucose-related conditions such as dysglycemia and pre-diabetes. The software supports clinician-directed care and references CPT codes for billing, while providers retain full clinical authority.

1 investor

BioConsortia develops microbial products for agriculture, including nitrogen-fixation, biocontrol, and biostimulant solutions for crops. The company uses proprietary microbial discovery and optimization tools to build its product portfolio.

0 investors

0 investors

BioCorteX builds a biology-based knowledge graph of microbiome samples (Carbon Knowledge) and a foundational emulator (Carbon Mirror) that models interactions between bacteria, the human immune system, diseases, and drugs to generate insights for drug discovery and development. Its products serve the pharmaceutical and therapeutics industry.

1 investor

BioCorteX develops personalized therapeutics using a microbiome knowledge graph and proprietary biology emulation platform to tailor drug treatments for diverse populations. The company aims to improve treatment efficacy across different communities by accounting for individual microbiome variations in drug development.

1 investor

BioCraft Pet Nutrition develops cell-cultured nutrition for cats and dogs, producing key nutrients for carnivorous pets without relying on conventionally farmed animals. The company focuses on pet food that reduces the environmental impact of animal-based ingredients.

1 investor

BiocSol develops microbial-free biopesticides that combine active compounds with complementary mechanisms of action to help farmers protect crops as an alternative to synthetic pesticides. The company originated from plant health and microbiology research at UCLouvain, initially targeting potato crops in Wallonia, Belgium.

2 investors

Biocule sells face serums formulated for different skin types, using ECOCERT-certified ingredients and manufactured in a WHO-GMP certified facility. Its skincare products are dermatologically tested.

1 investor

0 investors

0 investors

0 investors

BioCytics conducts translational cancer research, including a project with UNC Charlotte and Carolina BioOncology Institute to study the "dark genome" of cancer cells to identify sequences involved in tumor growth, immune response, and treatment response. Its work spans cell therapy, neoantigens, tumor infiltrating lymphocytes, and clinical research informatics.

0 investors

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.

1 investor

Biodata Bank develops Canaria+, a wearable wrist device that detects rising internal body temperature and warns workers of heat-related risks through sound, light, and vibration alarms without requiring charging, connectivity, or setup. It is aimed at companies protecting field and industrial workers from heatstroke, and the reusable devices are collected and refurbished to reduce waste.

1 investor

0 investors

BioDefense makes BioFresh, an edible, plant-derived protective coating that extends the shelf life of perishable foods like meat, fish, and seafood without chemical preservatives. The colorless, odorless coating preserves freshness and nutrition, prevents pathogen growth, and reduces food waste across the food supply chain.

1 investor

0 investors

Bio Design Lab develops biopharmaceuticals using synthetic biology and systems-level genetic and genomic design. Its initial focus is advancing retroviral and lentiviral vector platforms that serve as foundational technologies for cell and gene therapies.

1 investor

0 investors